Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-6-20
pubmed:abstractText
Infection with Mycobacterium tuberculosis (TB) induces pulmonary immunopathology mediated by classical Th1 type of acquired immunity with hepatic involvement in up to 80% of disseminated cases. Since PPAR agonists cause immune responses characterized by a decrease in the secretion of Th1 cytokines, we investigated the impact of activating these receptors on hepatic pathology associated with a well-characterized model of Th1-type pulmonary response. Male Fischer 344 rats were either maintained on a drug-free diet (groups I and II), or a diet containing diethylhexylphthalate (DEHP), a compound transformed in vivo to metabolites known to activate PPARs, for 21 days (groups III and IV). Subsequently, animals were primed with Mycobacterium bovis purified protein derivative (PPD) in a Complete Freund's Adjuvant. Fifteen days later, animals in groups II and IV were challenged with Sepharose 4B beads covalently coupled with PPD, while animals in groups I and III received blank Sepharose beads. Animals with Th1 response (group II) showed a marked structural disruption in the hepatic lobule. Remarkably, these alterations were conspicuously absent in animals which received DEHP (group IV), despite noticeable accumulation of T cells in the periportal triads. Immunostaining and confocal microscopy revealed hepatic accumulation of IFNgamma+ Th1 and IL-4+ Th2 cells in animals from groups II and IV, respectively. Our data suggest a PPARalpha-mediated suppression of the development of a Th1 immune response in the liver, resulting in hepatoprotective effect. However, potentially negative consequences of PPAR activation, such as decreased ability of the immune system to fight infection and interference with the efficacy of vaccines designed to evoke Th1 immune responses, remain to be investigated.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-10504144, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-10581215, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-11049818, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-11290568, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-12393563, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-14527086, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-14594621, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-15239090, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-15618469, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-15619473, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-15674127, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-16792681, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-2210202, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-2792462, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-3317819, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-8817083, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-9021963, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-9071315, http://linkedlifedata.com/resource/pubmed/commentcorrection/18566640-9493760
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:issn
1687-4757
pubmed:author
pubmed:issnType
Print
pubmed:volume
2007
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
49671
pubmed:year
2007
pubmed:articleTitle
Phthalate-Induced Liver Protection against Deleterious Effects of the Th1 Response: A Potentially Serious Health Hazard.
pubmed:affiliation
Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA.
pubmed:publicationType
Journal Article